Search Results - DeTakats, P.

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition

    Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition by FERRY, D. R, SMITH, A, MALKHANDI, J, FYFE, D. W, DETAKATS, P. G, ANDERSON, D, BAKER, J, KERR, D. J

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A randomized phase II-study of BB-10010 (macrophage inflammatory protein-1α) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy

    A randomized phase II-study of BB-10010 (macrophage inflammatory protein-1α) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chem... by CLEMONS, M. J, MARSHALL, E, DETAKATS, P, TESTA, N. G, DOUGAL, M, HUNTER, M. G, WOOD, L. M, CZAPLEWSKI, L. G, MILLAR, A, DEXTER, T. M, LORD, B. I, DÜRIG, J, WATANABE, K, HOWELL, A, MILES, D, EARL, H, KIERNAN, J, GRIFFITHS, A, TOWLSON, K

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A Randomized Phase-II Study of BB-10010 (Macrophage Inflammatory Protein- 1) in Patients With Advanced Breast Cancer Receiving 5-Fluorouracil, Adriamycin, and Cyclophosphamide Chemotherapy

    A Randomized Phase-II Study of BB-10010 (Macrophage Inflammatory Protein- 1) in Patients With Advanced Breast Cancer Receiving 5-Fluorouracil, Adriamycin, and Cyclophosphamide Che... by Clemons, Mark J., Marshall, Ernest, Dürig, Jan, Watanabe, Ken, Howell, Anthony, Miles, David, Earl, Helena, Kiernan, Julie, Griffiths, Audrey, Towlson, K., DeTakats, P., Testa, Nydia G., Dougal, Mark, Hunter, Michael G., Wood, L. Michael, Czaplewski, Lloyd G., Millar, Andrew, Dexter, T. Michael, Lord, Brian I.

    Published in Blood
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  4. 4
    Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases?: Arbiter

    Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases?: Arbiter by de Takats, P.G., J. Kerr, D

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Hepatic arterial chemotherapy for metastatic colorectal carcinoma

    Hepatic arterial chemotherapy for metastatic colorectal carcinoma by DE TAKATS, P. G, KERR, D. J, POOLE, C. J, WARREN, H. W, MCARDLE, C. S

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Symptomatic cardiomyopathy as a presentation in Whipple's disease

    Symptomatic cardiomyopathy as a presentation in Whipple's disease by de Takats, P. G., de Takats, D. L., Iqbal, T. H., Watson, R. D., Sheppard, M. N., Cooper, B. T.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Determination of quercetin in human plasma using reversed-phase high-performance liquid chromatography

    Determination of quercetin in human plasma using reversed-phase high-performance liquid chromatography by Liu, B, Anderson, D, Ferry, D R, Seymour, L W, de Takats, P G, Kerr, D J

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Role and regulation of phospholipase D activity in normal and cancer cells

    Role and regulation of phospholipase D activity in normal and cancer cells by Wakelam, Michael J.O., Martin, Ashley, Hodgkin, Matthew N., Brown, Fraser, Pettitt, Trevor R., Cross, Michael J., De Takats, Philippa G., Reynolds, Joanne L.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Is cholesterol embolic disease an unrecognized cause of renal graft dysfunction ?

    Is cholesterol embolic disease an unrecognized cause of renal graft dysfunction ? by DE TAKATS, D. L. P, POLLOCK, L. E, O'DONNELL, P. J, SNOWDEN, S, BEWICK, M, SCOBLE, J. E

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: